Study on lipoprotein(a) and clot breakdown in heart disease
Part of Heart & circulation clinical trials.
This trial looks at how a type of fat in the blood called lipoprotein(a) and your body's ability to break down clots affect heart disease or heart valve disease. It is for people who are already taking certain cholesterol-lowering medicines or have severe aortic valve narrowing from calcium buildup.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are already taking a PCSK9 inhibitor or inclisiran for cholesterol, OR have been diagnosed with moderate or severe aortic stenosis (a narrowed heart valve) on a CT scan
- You are willing to have blood samples taken for this study
- You do not have any medical condition that would make it unsafe, such as a bleeding disorder, or you are not taking part in another trial with an unapproved drug or device
- You agree to drink no more than 14 units of alcohol per week
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine called lepodisiran can shrink plaque in heart arteries for adults with high Lp(a) (a type of cholesterol linked to heart disease) who have had a heart event or are at serious risk. The trial uses CT scans to monitor changes in your arteries.
This study looks at how blood-thinning medications (like aspirin and clopidogrel) work in people with hardened arteries or peripheral artery disease (PAD). By understanding this, doctors hope to improve treatment and prevent heart attacks and strokes.
This study looks at whether a type of fat in your blood, called lipoprotein(a), can help predict how well you do after a planned procedure to open a blocked heart artery. If you join, we will take a blood sample before the procedure and follow your recovery to see how lipoprotein(a) levels relate to outcomes.
This study looks at levels of a type of cholesterol called Lp(a) in people with certain heart and blood vessel diseases. The goal is to understand how common high Lp(a) is in Russian adults with these conditions.
This study looks at how well two common blood thinners (aspirin and clopidogrel) work in people with high levels of Lp(a), a type of fat in the blood linked to heart disease. It may help doctors understand if these people need different treatment.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
Hear when a new Atherosclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.